Spain· ES:60713
OPTIRAY ULTRAJECT 240 mg/ml SOLUCION INYECTABLE
A medicinal product containing ioversol, registered in Spain by Guerbet.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- ioversol
- Manufacturer
- Guerbet
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ioversol in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumOptiject 240 mg I/mlGuerbet
- CzechiaOPTIRAYGuerbet, Roissy CdG Cedex
- United KingdomOptiray 160 solution for infusion 50ml bottlesCovidien (UK) Commercial Ltd
- Japanイオベルソールゲルベ・ジャパン
- FinlandOptirayGuerbet
- United StatesOptirayLiebel-Flarsheim Company LLC
- SwedenOptiray (flerdos) 300 mg I/ml Injektions-/infusionsvätska, lösningGuerbet
- IrelandOptiray 300 mg I/ml PFS solution for injectionGuerbet
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Optiray
- Belgium · Optiject, Optiray
- Czechia · Optiray
- Germany · Optiray
- Denmark · Optiray
- Finland · Optiray
- France · Optiject, Optiray
- United Kingdom (Northern Ireland) · Optiray
- Greece · Optiray
- Croatia · Optiray
- Hungary · Optiray
- Ireland · Optiray
- Italy · Optiray
- Luxembourg · Optiject, Optiray
- Netherlands · Optiray
- Norway · Optiray
- Poland · Optiray
- Portugal · Optiray
- Romania · Optiray
- Sweden · Optiray
- Slovakia · Optiray
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/82209319-ba28-4510-a0ce-84c3df22318a GET /v1/drugs/82209319-ba28-4510-a0ce-84c3df22318a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario Y Centros De Diagnóstico Autorizados",
"estado": "{\"aut\":794012400000,\"rev\":1745333771000}",
"nregistro": "60713",
"substance": "ioversol"
}See everything about ioversol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.